| GR00053-A |
339500 |
NM_178549 |
MGC42493 |
np |
sp |
none |
|
no |
|
Genome stability |
A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. |
Paulsen et al. |
2009 |
19647519 |
Cell line |
HeLa |
gamma-H2AX phosphorylation and DNA content |
Fluorescence |
siARRAY human genome siRNA library |
Genome-wide |
siRNA |
p-value |
Complex criteria |
Confidence groupings from 4 to 1 (highest level of confidence in group 4) |
GR00054-A |
339500 |
NM_178549 |
MGC42493 |
np |
0.741 |
none |
|
no |
|
Combinatorial effect with paclitaxel |
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. |
Whitehurst et al. |
2007 |
17429401 |
Cell line |
NCI-H1155 |
Viability (synthetic lethal) |
ATP level |
# G-005000-01 |
Genome-wide |
siRNA |
Paclitaxel/control ratio |
Complex criteria |
Additional information about 87 high-confidence hits |
GR00056-A |
339500 |
NM_178549 |
MGC42493 |
np |
1.048 |
none |
|
no |
|
Melanogenesis |
Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. |
Ganesan et al. |
2008 |
19057677 |
Cell line |
MNT-1 |
Melanin protein expression and viability |
Absorbance and luminescence |
rp |
Genome-wide |
siRNA |
Normalized absorbance ratio |
> 2 standard deviations below mean |
Additional information about a secondary screen (retest to determine false-positive rate) |
GR00057-A-1 |
339500 |
NM_178549 |
MGC42493 |
M-018005-00 |
0.27 |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (1) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Z-score |
> 4 |
Screen without Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00057-A-2 |
339500 |
NM_178549 |
MGC42493 |
M-018005-00 |
sp |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (2) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Complex, SP |
Complex criteria |
Screen with Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00180-A-1 |
339500 |
339500 |
ZNF678 |
PL-50079 |
0.884 |
none |
|
no |
|
Hepatitis C virus replication (1) |
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. |
Tai et al. |
2009 |
19286138 |
Cell line |
Huh7/Rep-Feo |
HCV replicon RNA copy number |
Luminescence |
siARRAY Human Genome siRNA Library |
Genome-wide |
siRNA |
q-value |
Complex criteria |
|
GR00180-A-1 |
339500 |
84841 |
MGC15634 |
PL-50068 |
0.923 |
none |
|
no |
|
Hepatitis C virus replication (1) |
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. |
Tai et al. |
2009 |
19286138 |
Cell line |
Huh7/Rep-Feo |
HCV replicon RNA copy number |
Luminescence |
siARRAY Human Genome siRNA Library |
Genome-wide |
siRNA |
q-value |
Complex criteria |
|
GR00184-A-1 |
339500 |
NM_178549 |
ZNF678 |
M-018005-00 |
-0.504784332443088 |
none |
|
no |
|
Self-renewal and pluripotency in human embryonic stem cells (1) |
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. |
Chia et al. |
2010 |
20953172 |
Cell line |
hESC H1 |
POU5F1 protein expression |
Fluorescence |
SMARTpool siRNA library |
Genome-wide |
siRNA |
Z-score |
< -2 |
|
GR00197-A-1 |
339500 |
84841 |
MGC15634 |
M-014984-00 |
0.409165477 |
none |
|
no |
|
Human papillomavirus oncogene expression regulation (1) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Phenotype strength according to Z-scores: weak: 2 - 3; moderate: 3 - 5; strong: > 5 |
GR00197-A-1 |
339500 |
339500 |
MGC42493 |
M-018005-00 |
3.088570945 |
Increased HPV18 LCR reporter activity |
|
yes |
deconvoluted validated siRNAs: 1 |
Human papillomavirus oncogene expression regulation (1) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Phenotype strength according to Z-scores: weak: 2 - 3; moderate: 3 - 5; strong: > 5 |
GR00197-A-3 |
339500 |
339500 |
ZNF678 |
D-018005-04 |
-3.945 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (3) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-3 |
339500 |
339500 |
ZNF678 |
D-018005-01 |
0.177 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (3) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-3 |
339500 |
339500 |
ZNF678 |
D-018005-02 |
1.911 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (3) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-3 |
339500 |
339500 |
ZNF678 |
D-018005-03 |
8.443 |
Increased HPV18 LCR reporter activity |
|
yes |
|
Human papillomavirus oncogene expression regulation (3) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-4 |
339500 |
339500 |
ZNF678 |
D-018005-01 |
-0.613 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (4) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/16E2/18LCR clone 1 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-4 |
339500 |
339500 |
ZNF678 |
D-018005-04 |
-0.194 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (4) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/16E2/18LCR clone 1 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-4 |
339500 |
339500 |
ZNF678 |
D-018005-02 |
7.35 |
Increased HPV18 LCR reporter activity |
|
yes |
|
Human papillomavirus oncogene expression regulation (4) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/16E2/18LCR clone 1 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-4 |
339500 |
339500 |
ZNF678 |
D-018005-03 |
10.945 |
Increased HPV18 LCR reporter activity |
|
yes |
|
Human papillomavirus oncogene expression regulation (4) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/16E2/18LCR clone 1 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00197-A-5 |
339500 |
339500 |
ZNF678 |
D-018005-04 |
-1.876 |
Decreased BPV1 E2 protein expression |
|
yes |
|
Human papillomavirus oncogene expression regulation (5) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
BPV1 E2 protein expression |
Fluorescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
< |
Author-reviewed data |
GR00197-A-5 |
339500 |
339500 |
ZNF678 |
D-018005-03 |
-0.074 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (5) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
BPV1 E2 protein expression |
Fluorescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
< |
Author-reviewed data |
GR00197-A-5 |
339500 |
339500 |
ZNF678 |
D-018005-02 |
0.012 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (5) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
BPV1 E2 protein expression |
Fluorescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
< |
Author-reviewed data |
GR00197-A-5 |
339500 |
339500 |
ZNF678 |
D-018005-01 |
0.11 |
none |
|
yes |
|
Human papillomavirus oncogene expression regulation (5) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
BPV1 E2 protein expression |
Fluorescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
< |
Author-reviewed data |
GR00197-A-6 |
339500 |
339500 |
ZNF678 |
D-018005-01, D-018005-02, D-018005-03, D-018005-04 |
sp |
Increased HPV18 LCR reporter activity |
|
no |
E2-independent for HVP18 LCR repression |
Human papillomavirus oncogene expression regulation (6) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Selected genes |
siRNA |
Z-score |
np |
Author-reviewed data |
GR00215-A |
339500 |
|
ZNF678 |
v2HS_100460 |
1.2 |
Synthetic lethal with c-Myc after tamoxifen stimulation |
|
no |
|
Combinatorial effect with c-Myc |
A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. |
Kessler et al. |
2012 |
22157079 |
Cell line |
HMEC |
Viability (synthetic lethal) |
PCR and microarray |
shRNAmir |
Genome-wide |
shRNA |
log2 ratio |
> 1 |
|
GR00236-A-1 |
339500 |
339500 |
ZNF678 |
M-018005-00 |
1.21732150019885 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. |
Adamson et al. |
2012 |
22344029 |
Cell line |
DR-U2OS |
(HR-DSBR) DR-GFP reporter and DNA content |
Fluorescence |
Human siGENOME siRNA (G-005000-05) |
Genome-wide |
siRNA |
Relative HR ratio |
< ~0.4 OR > 1.88 |
Cutoff values correspond 2 standard deviations from the screen-wide mean |
GR00236-A-1 |
339500 |
84841 |
MGC15634 |
M-014984-00 |
0.75166127726336 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. |
Adamson et al. |
2012 |
22344029 |
Cell line |
DR-U2OS |
(HR-DSBR) DR-GFP reporter and DNA content |
Fluorescence |
Human siGENOME siRNA (G-005000-05) |
Genome-wide |
siRNA |
Relative HR ratio |
< ~0.4 OR > 1.88 |
Cutoff values correspond 2 standard deviations from the screen-wide mean |
GR00240-S-1 |
339500 |
NM_178549 |
MGC42493 |
M-018005-00 |
0.23 |
none |
|
yes |
|
TRAIL-induced apoptosis (1) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Z-score |
> 4 |
Author-submitted data |
GR00240-S-2 |
339500 |
NM_178549 |
MGC42493 |
M-018005-00 |
-1.22 |
none |
|
no |
Z-score -0.8465 |
TRAIL-induced apoptosis (2) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability (synthetic lethal) |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Differential score |
> 3.6 AND viability Z-score < 4 |
Author-submitted data. Z-scores from viability screen (1) are considered in score interpretation for this screen. |
GR00242-A-1 |
339500 |
NM_178549 |
MGC42493 |
np |
sp |
none |
|
no |
|
Selective autophagy regulation (1) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
siGenome |
Genome-wide |
siRNA |
Z-score |
Complex criteria |
|
GR00247-A-1 |
339500 |
|
ZNF678 |
np |
sp |
none |
|
|
rank: 14540 |
Regulation of FOXO1 nuclear localization (1) |
Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. |
Senapedis et al. |
2011 |
21460183 |
Cell line |
U2OS |
EGFP-FOXO1a protein expression and DNA content |
Fluorescence |
Human Genome library |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
|
GR00249-S |
339500 |
339500 |
MGC42493 |
J-018005-17 |
-1.22963 |
none |
|
no |
number of cells compared to control (%): 94.90 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
339500 |
339500 |
MGC42493 |
M-018005-00 |
-0.03287 |
none |
|
no |
number of cells compared to control (%): 95.34 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
339500 |
339500 |
ZNF678 |
s50550 |
-0.81034 |
none |
|
no |
number of cells compared to control (%): 54.69 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
339500 |
339500 |
ZNF678 |
s50551 |
-0.08388 |
none |
|
no |
number of cells compared to control (%): 86.53 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
339500 |
339500 |
ZNF678 |
s50552 |
-1.33933 |
none |
|
no |
number of cells compared to control (%): 60.72 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00250-A-1 |
339500 |
339500 |
ZNF678 |
M-018005-00 |
sp |
Synthetic lethal with MLN4924 (a NAE inhibitor) |
|
|
duplicate screen, sextuplicate screen |
Combinatorial effect with MLN4924, a NAE inhibitor (1) |
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. |
Blank et al. |
2013 |
23100467 |
Cell line |
A375 |
Viability (synthetic lethal) |
Luminescence |
np |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
Phenotypes for 650 nmol/L MLN4924. Additional information about screens with 250 nmol/L MLN4924. |
GR00250-A-2 |
339500 |
339500 |
ZNF678 |
D-018005-01 |
sp |
Synthetic lethal with MLN4924 (a NAE inhibitor) |
|
|
duplicate screen |
Combinatorial effect with MLN4924, a NAE inhibitor (2) |
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. |
Blank et al. |
2013 |
23100467 |
Cell line |
A375 |
Viability (synthetic lethal) |
Luminescence |
np |
Selected genes |
siRNA |
Complex, sp |
Complex criteria |
Phenotypes for 650 nmol/L MLN4924. Additional information about screens with 250 nmol/L MLN4924. |
GR00250-A-2 |
339500 |
339500 |
ZNF678 |
D-018005-02 |
sp |
Synthetic lethal with MLN4924 (a NAE inhibitor) |
|
|
duplicate screen |
Combinatorial effect with MLN4924, a NAE inhibitor (2) |
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. |
Blank et al. |
2013 |
23100467 |
Cell line |
A375 |
Viability (synthetic lethal) |
Luminescence |
np |
Selected genes |
siRNA |
Complex, sp |
Complex criteria |
Phenotypes for 650 nmol/L MLN4924. Additional information about screens with 250 nmol/L MLN4924. |
GR00250-A-2 |
339500 |
339500 |
ZNF678 |
D-018005-03 |
sp |
none |
|
|
duplicate screen |
Combinatorial effect with MLN4924, a NAE inhibitor (2) |
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. |
Blank et al. |
2013 |
23100467 |
Cell line |
A375 |
Viability (synthetic lethal) |
Luminescence |
np |
Selected genes |
siRNA |
Complex, sp |
Complex criteria |
Phenotypes for 650 nmol/L MLN4924. Additional information about screens with 250 nmol/L MLN4924. |
GR00250-A-2 |
339500 |
339500 |
ZNF678 |
D-018005-04 |
sp |
Synthetic lethal with MLN4924 (a NAE inhibitor) |
|
|
duplicate screen |
Combinatorial effect with MLN4924, a NAE inhibitor (2) |
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. |
Blank et al. |
2013 |
23100467 |
Cell line |
A375 |
Viability (synthetic lethal) |
Luminescence |
np |
Selected genes |
siRNA |
Complex, sp |
Complex criteria |
Phenotypes for 650 nmol/L MLN4924. Additional information about screens with 250 nmol/L MLN4924. |
GR00253-A |
339500 |
NM_178549 |
MGC42493 |
np |
1.724 |
none |
|
|
|
hepcidin regulation |
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. |
Mleczko-Sanecka et al. |
2014 |
24385536 |
Cell line |
Huh7 |
hepcidin::fluc mRNA expression |
Luminescence |
siGenome siARRAY SMARTpool |
Genome-wide |
siRNA |
Z-score |
> |
Cutoff < |
GR00255-A-1 |
339500 |
339500 |
ZNF678 |
TRCN0000018168, TRCN0000018169, TRCN0000018170, TRCN0000018171, TRCN0000018172 |
0.073871841 |
none |
|
|
|
Negative genetic interactions (1) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 BLM-/- and HCT116 BLM+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-2 |
339500 |
339500 |
ZNF678 |
TRCN0000018168, TRCN0000018169, TRCN0000018170, TRCN0000018171, TRCN0000018172 |
0.377477196 |
none |
|
|
|
Negative genetic interactions (2) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 MUS81-/- and HCT116 MUS81+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-3 |
339500 |
339500 |
ZNF678 |
TRCN0000018168, TRCN0000018169, TRCN0000018170, TRCN0000018171, TRCN0000018172 |
-0.050627675 |
none |
|
|
|
Negative genetic interactions (3) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTEN-/- and HCT116 PTEN+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-4 |
339500 |
339500 |
ZNF678 |
TRCN0000018168, TRCN0000018169, TRCN0000018170, TRCN0000018171, TRCN0000018172 |
0.173185154 |
none |
|
|
|
Negative genetic interactions (4) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTTG1-/- and HCT116 PTTG1+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-5 |
339500 |
339500 |
ZNF678 |
TRCN0000018168, TRCN0000018169, TRCN0000018170, TRCN0000018171, TRCN0000018172 |
-0.201911129 |
none |
|
|
|
Negative genetic interactions (5) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -0.8 |
HCT116 KRASG13D/- and HCT116 KRAS+/- cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00300-A |
339500 |
|
ZNF678 |
TRCN0000018168, TRCN0000018169, TRCN0000018170, TRCN0000018171, TRCN0000018172 |
0 |
none |
|
|
|
Combinatorial effect with RAF inhibitor PLX4720 |
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. |
Whittaker et al. |
2013 |
23288408 |
Cell line |
A375 |
shRNA abundance |
Sequencing |
TRC |
Genome-wide |
shRNA |
Number of shRNAs ranked Top1000 |
> 2 |
The A375 cell line used here harbours the BRAF V600E mutation and is therefore sensitive to RAF inhibitors. |
GR00303-A |
339500 |
NM_178549 |
MGC42493 |
np |
-1.56 |
none |
|
|
|
Clear cell renal cell carcinoma (ccRCC) survival regulation |
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target |
Gerlinger et al. |
2012 |
22362593 |
Cell line |
VHL-deficient RCC4 |
Proliferation and Viability |
Fluorescence |
np |
Genome-wide |
siRNA |
Z-score |
< |
In the phenotype data duplicates were in the original document, which have been removed. |
GR00310-A-1 |
339500 |
339500 |
MGC42493 |
np |
0.41 |
none |
|
|
|
Sindbis virus (SINV) infection (1) |
Genome-Wide RNAi Screen Identifies Novel Host Proteins Required for Alphavirus Entry |
Ooi et al. |
2013 |
24367265 |
Cell line |
U2OS |
Sindbis virus (SINV) reporter |
Luminescence |
Ambion Silencer V3 |
Genome-wide |
siRNA |
Z-score |
< -3 OR > 2 |
|
|
339500 |
339500 |
ZNF678 |
np |
13.7 |
none |
|
|
83,2% viability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00313-A |
339500 |
NM_178549 |
MGC42493 |
np |
0.48 |
none |
|
|
|
TNF-alpha pathway regulation |
A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling. |
Nickles et al. |
2012 |
22733992 |
Cell line |
HEK293T |
NFkappaB pathway reporter |
Luminescence |
Qiagen |
Genome-wide |
siRNA |
Z-score |
< |
Additional filters were a reduction in firefly luciferase levels by at least 50% compared to the mean of the experiment and a concomitant reduction of renilla luciferase expression of not more than 30%. |
GR00343-S |
339500 |
339500 |
ZNF678 |
TRCN0000018169 |
0.7850000000000001 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
339500 |
339500 |
ZNF678 |
TRCN0000018171 |
1.875 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
339500 |
339500 |
ZNF678 |
TRCN0000018172 |
1.0875000000000004 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
339500 |
339500 |
ZNF678 |
TRCN0000018168 |
1.3550000000000004 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
339500 |
339500 |
ZNF678 |
TRCN0000018170 |
-0.5300000000000011 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
|
339500 |
|
ZNF678 |
np |
1 |
Resistant to vaccinia virus (VACV-A4L) infection |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00364-A |
339500 |
339500 |
ZNF678 |
np |
-4.670877785532214 |
Decreased Salmonella proliferation |
|
|
|
Salmonella infection |
Human Genome-Wide RNAi Screen for Host Factors that modulate intracellular Salmonella Growth |
Thornbrough et al. |
2012 |
3372477 |
Cell line |
MCF-7 |
Intracellular bacterial proliferation |
Fluorescence |
siRNA library v1.0, Qiagen |
Genome-wide |
siRNA |
Standard deviations |
> |
|
|
339500 |
339500 |
ZNF678 |
|
0.05 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00371-A-1 |
339500 |
339500 |
ZNF678 |
|
0.0386400503325 |
none |
|
|
Ambion |
Nanog expression in absence of bFGF and TGFbeta |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-2 |
339500 |
ZNF678 |
339500 |
|
0.00483032754034 |
none |
|
|
Ambion |
Nanog expression in presence of TGFbeta inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-3 |
339500 |
339500 |
ZNF678 |
|
-0.944962009613 |
none |
|
|
Ambion |
Nanog expression in presence of MEK inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-4 |
339500 |
339500 |
ZNF678 |
|
-0.894678647398 |
none |
|
|
Ambion |
Nanog expression in presence of PI3K inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-5 |
339500 |
339500 |
ZNF678 |
|
-0.0138647412007 |
none |
|
|
Ambion |
Nanog expression in presence of retinoic acid |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00376-A-1 |
339500 |
339500 |
ZNF678 |
|
0.071466114 |
none |
|
|
|
Mitigators of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "high dose", ≈EC90, 13 ng/ml. Cutoff was derived from data submitted to Pubchem (ID 1117281). Reagent sequences but no ID |
GR00376-A-2 |
339500 |
339500 |
ZNF678 |
|
0.296060226 |
none |
|
|
|
Sensitizers of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "low dose", ≈EC30, 3 ng/ml. Cutoff was derived from data submitted to PubChem (ID 1117281). Reagent sequences but no ID |
|
339500 |
NM_178549 |
ZNF678 |
|
79.98 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00386-A-1 |
339500 |
339500 |
ZNF678 |
|
90.0898758430066 |
none |
|
|
|
NOD2 stimulation by MDP |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
Viability |
Luminescence |
Dharmacon |
Genome-wide |
siRNA |
Percentage growth |
Decreased: <70, increased: >120 |
Reagent IDs not provided |
GR00386-A-2 |
339500 |
339500 |
ZNF678 |
|
-93.7 |
none |
|
|
|
MDP-induced IL-8 secretion |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
IL-8 secretion |
ELISA |
Dharmacon |
Genome-wide |
siRNA |
Percent inhibition of IL-8 secretion |
Increased: <-300, Decreased: >60 |
Concentration of IL-8 was measured from cell supernatants by sandwich ELISA. IL-8 values (pg/ml) were normalized to IL-8 secreted in cells treated with RIPK2-specific siRNA (100% inhibition) and non-targeting siRNA (0% inhibition). Secondary validating screen assessed 554 genes whose silencing affected MDP-induced IL-8 secretion in the primary screen. Final validated IL-8 regulators (positive or negative) are listed in the comments column. Reagent IDs not provided |